Shire sells oncology assets

Shire Plc announced on 16 April that it has reached a deal to sell its oncology business to Servier SAS of France for $2.4 billion. The transaction was described by the company as a move to sharpen its focus on its portfolio for drugs treating rare diseases.

Full text available to subscribers only. Click here for information on subscribing to MedNous.